You are here

MITOTHERAPEUTIX, LLC

Company Information
Address
400 FARMINGTON AVE
FARMINGTON, CT 06032-1913
United States



Information

UEI: QNXLAMDAM5Y4

# of Employees: 1


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: Yes

Woman Owned: No



Award Charts




Award Listing

  1. Novel Treatment for Alcohol-associated Liver Disease

    Amount: $273,918.00

    Abstract The Specific Aim of this Phase I TTR proposal is to test the feasibility of our siRNA drug to ameliorate the pathology and progression of alcohol-associated liver disease (ALD). Alcohol consu ...

    STTRPhase I2023Department of Health and Human Services National Institutes of Health
  2. A novel approach to treat non-alcoholic steatohepatitis (NASH)

    Amount: $1,869,241.00

    Abstract The goal of this SBIR fast-track application is to carry out a number of IND enabling studies on our siRNA drug candidate, which is designed to treat non-alcohol steatohepatitis (NASH). NASH ...

    SBIRPhase II2022Department of Health and Human Services National Institutes of Health
  3. A novel approach to treat non-alcoholic steatohepatitis (NASH)

    Amount: $253,050.00

    Abstract The goal of this SBIR fast-track application is to carry out a number of IND enabling studies on our siRNA drug candidate, which is designed to treat non-alcohol steatohepatitis (NASH). NASH ...

    SBIRPhase I2021Department of Health and Human Services National Institutes of Health
  4. A novel therapeutic to address fatty liver in post-parturient dairy cows

    Amount: $100,000.00

    The prevalence of fatty liver in dairy cows can be as high as 50%.Consequences of fatty liver include decreased reproductive success suppressedimmune functions ketosis retained fetal membranes endomet ...

    SBIRPhase I2020Department of Agriculture
  5. A Novel Treatment for Acetominophen-Induced Liver Injury

    Amount: $264,238.00

    Abstract The Specific Aim of this Phase I STTR proposal is to test the feasibility of blocking MCJalso called DnaJCto overcome acute acetaminophen liver toxicityAcetaminophen or APAPfrom acetyl paraam ...

    STTRPhase I2018Department of Health and Human Services National Institutes of Health
  6. A novel approach to treat non alcoholic steatohepatitis NASH

    Amount: $317,953.00

    Abstract The Specific Aim of this Phase I STTR proposal is to test the feasibility of treating non alcohol steatohepatitis NASH by increasing mitochondrial metabolism which is the main pathway for ...

    STTRPhase I2017Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government